Safety Study of CN-105 Neuroprotective Peptide for Intracerebral Hemorrhage

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study evaluates the safety, tolerability, and pharmacokinetics (PK) of a single escalating dose and repeated doses of CN-105 in healthy adult participants. There will be about 48 subjects, 36 active and 12 placebo.
Epistemonikos ID: cb6cd9b3f41b87f2f9a7a65a05f3465cf20b6637
First added on: May 12, 2024